INTS
Price
$0.25
Change
-$0.00 (-0.00%)
Updated
Sep 24, 04:59 PM (EDT)
Capitalization
12.11M
55 days until earnings call
JWCTF
Price
$0.53
Change
-$0.13 (-19.70%)
Updated
Sep 23 closing price
Capitalization
236.01M
Interact to see
Advertisement

INTS vs JWCTF

Header iconINTS vs JWCTF Comparison
Open Charts INTS vs JWCTFBanner chart's image
Intensity Therapeutics
Price$0.25
Change-$0.00 (-0.00%)
Volume$100
Capitalization12.11M
JW CAYMAN THERAPEUTICS
Price$0.53
Change-$0.13 (-19.70%)
Volume$257
Capitalization236.01M
INTS vs JWCTF Comparison Chart in %
Loading...
INTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JWCTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INTS vs. JWCTF commentary
Sep 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INTS is a Hold and JWCTF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 25, 2025
Stock price -- (INTS: $0.25 vs. JWCTF: $0.53)
Brand notoriety: INTS and JWCTF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INTS: 33% vs. JWCTF: 2%
Market capitalization -- INTS: $12.11M vs. JWCTF: $236.01M
INTS [@Biotechnology] is valued at $12.11M. JWCTF’s [@Biotechnology] market capitalization is $236.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INTS’s FA Score shows that 0 FA rating(s) are green whileJWCTF’s FA Score has 1 green FA rating(s).

  • INTS’s FA Score: 0 green, 5 red.
  • JWCTF’s FA Score: 1 green, 4 red.
According to our system of comparison, JWCTF is a better buy in the long-term than INTS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INTS’s TA Score shows that 5 TA indicator(s) are bullish while JWCTF’s TA Score has 3 bullish TA indicator(s).

  • INTS’s TA Score: 5 bullish, 4 bearish.
  • JWCTF’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, INTS is a better buy in the short-term than JWCTF.

Price Growth

INTS (@Biotechnology) experienced а +2.83% price change this week, while JWCTF (@Biotechnology) price change was -19.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.90%. For the same industry, the average monthly price growth was +10.70%, and the average quarterly price growth was +54.52%.

Reported Earning Dates

INTS is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+4.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JWCTF($236M) has a higher market cap than INTS($12.1M). JWCTF YTD gains are higher at: 226.728 vs. INTS (-85.977).
INTSJWCTFINTS / JWCTF
Capitalization12.1M236M5%
EBITDA-12.56MN/A-
Gain YTD-85.977226.728-38%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash2.22MN/A-
Total Debt125KN/A-
TECHNICAL ANALYSIS
Technical Analysis
INTSJWCTF
RSI
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 3 days ago
39%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
53%
MACD
ODDS (%)
Bullish Trend 2 days ago
58%
Bearish Trend 2 days ago
58%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
63%
Bearish Trend 2 days ago
54%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
63%
Advances
ODDS (%)
Bullish Trend 3 days ago
70%
N/A
Declines
ODDS (%)
Bearish Trend 13 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
75%
N/A
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
24%
View a ticker or compare two or three
Interact to see
Advertisement
INTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JWCTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GRNQ1.440.06
+4.09%
Greenpro Capital Corp
CIVI33.230.63
+1.93%
Civitas Resources
GCMG12.88N/A
N/A
GCM Grosvenor
FSLR215.73-3.47
-1.58%
First Solar
TARA3.58-0.09
-2.45%
Protara Therapeutics

INTS and

Correlation & Price change

A.I.dvisor tells us that INTS and GBIO have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INTS and GBIO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INTS
1D Price
Change %
INTS100%
-5.00%
GBIO - INTS
29%
Poorly correlated
-0.86%
MRKR - INTS
29%
Poorly correlated
-5.16%
ACAD - INTS
28%
Poorly correlated
-3.79%
GPCR - INTS
27%
Poorly correlated
-1.80%
CCCC - INTS
27%
Poorly correlated
-0.77%
More

JWCTF and

Correlation & Price change

A.I.dvisor tells us that JWCTF and HSITF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that JWCTF and HSITF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JWCTF
1D Price
Change %
JWCTF100%
-19.83%
HSITF - JWCTF
25%
Poorly correlated
N/A
CAPR - JWCTF
24%
Poorly correlated
+0.99%
SRRK - JWCTF
24%
Poorly correlated
+3.59%
INTS - JWCTF
23%
Poorly correlated
-5.00%
SRZN - JWCTF
15%
Poorly correlated
-0.98%
More